Literature DB >> 12044569

Encapsulation-induced aggregation and loss in activity of gamma-chymotrypsin and their prevention.

Ingrid J Castellanos1, Gloydian Cruz, Rubén Crespo, Kai Griebenow.   

Abstract

Development of alternative procedures to the commonly employed water-in-oil-in-water technique to encapsulate proteins in polymers is needed due to protein stability issues. Herein the model protein gamma-chymotrypsin has been encapsulated in poly(D,L-lactic-co-glycolic)acid (PLGA) microspheres using the solid-in-oil-in-water (s/o/w) encapsulation technique. The model protein was chosen because it has a measurable biological activity and its unfolding is irreversible. The latter make the protein an excellent sensor for unfolding events in the encapsulation procedure. While lyophilization did not cause any irreversible aggregation or loss in activity, encapsulation of the lyophilized enzyme by the s/o/w technique proved detrimental to its integrity. Specifically, 34% of the encapsulated protein was aggregated and the specific activity of enzyme released within 24 h was reduced to ca. 50% of that prior to encapsulation. FTIR spectra demonstrated substantial encapsulation-induced perturbations of the secondary structure of gamma-chymotrypsin. To achieve stabilization of gamma-chymotrypsin during encapsulation, excipients were employed during the initial lyophilization process. When gamma-chymotrypsin was co-lyophilized with poly(ethylene glycol) (PEG) the formation of non-covalent aggregates inside the microspheres decreased significantly to 8%. FTIR data showed that PEG prevented encapsulation-induced structural perturbations. In contrast, the amount of aggregates remained high (34%) when gamma-chymotrypsin was co-lyophilized with trehalose. No additional non-soluble aggregates were formed during 1 week of in vitro release. Furthermore, the amount of non-soluble aggregates in the microspheres after encapsulation correlated with the amount of non-released protein. Therefore in vitro release did not cause aggregation. Similar results were found with respect to the retention of the specific enzyme activity where PEG afforded excellent stability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044569     DOI: 10.1016/s0168-3659(02)00073-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Nanoscaled buffering zone of charged (PLGA)n-b-bPEI micelles in acidic microclimate for potential protein delivery application.

Authors:  Han Chang Kang; Ji Eun Lee; You Han Bae
Journal:  J Control Release       Date:  2012-03-03       Impact factor: 9.776

2.  Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery.

Authors:  Tapan Kumar Giri; Chhatrapal Choudhary; Amit Alexander; Hemant Badwaik; Dulal Krishna Tripathi
Journal:  Saudi Pharm J       Date:  2012-05-26       Impact factor: 4.330

3.  Structural Stability of Recombinant Human Growth Hormone (r-hGH) as a Function of Polymer Surface Properties.

Authors:  Vaishnavi Rohitkumar Shah; Pardeep K Gupta
Journal:  Pharm Res       Date:  2018-03-15       Impact factor: 4.200

Review 4.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

5.  Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement.

Authors:  Ingrid J Castellanos; Kai Griebenow
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

6.  Structure of poly(ethylene glycol)-modified horseradish peroxidase in organic solvents: infrared amide I spectral changes upon protein dehydration are largely caused by protein structural changes and not by water removal per se.

Authors:  Wasfi Al-Azzam; Emil A Pastrana; Yancy Ferrer; Qing Huang; Reinhard Schweitzer-Stenner; Kai Griebenow
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

7.  Glycosylation improves α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic)acid microspheres.

Authors:  Giselle M Flores-Fernández; Kai Griebenow
Journal:  Results Pharma Sci       Date:  2012

8.  Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion.

Authors:  Xiaoyun Hong; Liangming Wei; Liuqing Ma; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2013-07-08

9.  Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres.

Authors:  Moraima Morales-Cruz; Giselle M Flores-Fernández; Myreisa Morales-Cruz; Elsie A Orellano; José A Rodriguez-Martinez; Mercedes Ruiz; Kai Griebenow
Journal:  Results Pharma Sci       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.